Medicare Poised to Add Important HIV Drug to Preventive Service List
August 8, 2024
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
Help protect Medicare’s future—support our 2025 Annual Benefit on Oct 28!
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
New Program to Help Willing Part D Plans Keep Premiums in Check
August 1, 2024
This week, the Centers for Medicare & Medicaid Services (CMS) announced a new project designed to help keep costs and
Guidance on Inflation Reduction Act’s Medicare Prescription Payment Plan Released
July 25, 2024
Last week, CMS released additional guidance regarding Medicare Prescription Payment Plan (MPPP) outreach and education. The MPPP, sometimes referred to
Medicare Reforms in the Inflation Reduction Act
July 1, 2024
The Inflation Reduction Act (IRA) of 2022 made key changes in Medicare law and coverage to improve prescription drug affordability for older adults and people with disabilities. Since its passage, some stakeholders and lawmakers have targeted IRA policies for revision or repeal, especially the law’s Medicare Drug Price Negotiation Program. Depending on the provisions targeted, this would increase beneficiary costs and increase Medicare spending.
Final Rules on Medicare Advantage Prior Authorization Offer Improvements, but More Change is Needed
May 30, 2024
Prior authorization is one of the processes Medicare Advantage and other private insurance companies use to manage health care utilization
Medicare Vaccine Uptake Increasing, Inflation Reduction Act’s Role Still Unknown to Many
May 16, 2024
Earlier this month, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
New Data on Impact of Inflation Reduction Act Shows Lower Health Care Costs for Women
April 25, 2024
Earlier this month, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
Study Shows Part D Plans Ratcheting Up Restrictions on Coverage
March 14, 2024
A new study from University of Southern California (USC) researchers shows that Medicare Part D plans have been increasingly restricting
Changes to Part D: Lower Out-Of-Pocket Drug Costs in 2024 and 2025; Simplifications in 2025
March 7, 2024
Many people with Medicare Part D drug coverage—in particular those who reach the catastrophic coverage phase—may experience unexpected costs and
Medicare Poised to Add Important HIV Drug to Preventive Service List
August 8, 2024
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
New Program to Help Willing Part D Plans Keep Premiums in Check
August 1, 2024
This week, the Centers for Medicare & Medicaid Services (CMS) announced a new project designed to help keep costs and
Guidance on Inflation Reduction Act’s Medicare Prescription Payment Plan Released
July 25, 2024
Last week, CMS released additional guidance regarding Medicare Prescription Payment Plan (MPPP) outreach and education. The MPPP, sometimes referred to
Medicare Reforms in the Inflation Reduction Act
July 1, 2024
The Inflation Reduction Act (IRA) of 2022 made key changes in Medicare law and coverage to improve prescription drug affordability for older adults and people with disabilities. Since its passage, some stakeholders and lawmakers have targeted IRA policies for revision or repeal, especially the law’s Medicare Drug Price Negotiation Program. Depending on the provisions targeted, this would increase beneficiary costs and increase Medicare spending.
Final Rules on Medicare Advantage Prior Authorization Offer Improvements, but More Change is Needed
May 30, 2024
Prior authorization is one of the processes Medicare Advantage and other private insurance companies use to manage health care utilization
Medicare Vaccine Uptake Increasing, Inflation Reduction Act’s Role Still Unknown to Many
May 16, 2024
Earlier this month, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
New Data on Impact of Inflation Reduction Act Shows Lower Health Care Costs for Women
April 25, 2024
Earlier this month, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
Study Shows Part D Plans Ratcheting Up Restrictions on Coverage
March 14, 2024
A new study from University of Southern California (USC) researchers shows that Medicare Part D plans have been increasingly restricting
Changes to Part D: Lower Out-Of-Pocket Drug Costs in 2024 and 2025; Simplifications in 2025
March 7, 2024
Many people with Medicare Part D drug coverage—in particular those who reach the catastrophic coverage phase—may experience unexpected costs and